Dramatic, significant metabolic response to a one‐time pembrolizumab treatment following a relapse of pre‐existing organizing pneumonia in a patient with advanced non‐small cell lung cancer: A case report

Immune checkpoint inhibitors can often trigger immune‐related adverse events (irAEs), such as relapse of pre‐existing interstitial pneumonia. Here, we report the case of an 88‐year‐Japanese man diagnosed with advanced lung adenocarcinoma with a high tumor proportion score of programmed death‐ligand...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Motoyasu, Mori, Mikiko, Miura, Keita, Asao, Tetsuhiko, Motomura, Hiroaki, Nishino, Koichi, Ko, Ryo, Koyama, Ryo, Hayashi, Takuo, Takahashi, Kazuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590898/
https://www.ncbi.nlm.nih.gov/pubmed/34617405
http://dx.doi.org/10.1111/1759-7714.14185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590898/
https://www.ncbi.nlm.nih.gov/pubmed/34617405
http://dx.doi.org/10.1111/1759-7714.14185

Ejemplares similares